Clinical trial
Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic…
NCT00209833 · Hannover Medical School, Other · Unknown status
Key facts
| NCT number | NCT00209833 |
|---|---|
| Title | Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T |
| Official title | Protocol for the Treatment of Adults Aged </= 60 Years With De Novo Acute Myeloblastic Leukaemia or Secondary AML or RAEB-T (AML 01/99 Trial) |
| Lead sponsor | Hannover Medical School, Other |
| Collaborators | University of Ulm Johann Wolfgang Goethe University Hospital University Hospital Freiburg University Hospital Augsburg Humboldt-Universität zu Berlin Universitätsklinikum Hamburg-Eppendorf University… |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | De Novo Akute Myeloid Leukemia (AML), Secondary Acute Myeloid Leukemia (AML), Refractory Anemia With Excess of Blasts in Transformation |
| Intervention type | Drug |
| Interventions | Cytarabine, Idarubicin, Etoposide, Fludarabine, G-CSF, Daunorubicine |
| Enrollment | 200 |
| Start date | Jan 1, 1999 |
| Completion | Sep 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | Nov 18, 2005 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: